Introduction

The CAPSULS™ patient isolation unit (PIU) was developed with transportation of patients in mind. It prevents cross-contamination between the patient and the external environment.

Originally developed to protect U.S. military personnel from potential radiological and nuclear exposure in middle east operations, it has since been adopted for use in transporting patients, who have highly contagious pathogens like ebola or COVID-19.

It is the ONLY such device that has been approved by the FDA for patient isolation transportation (510(k) K052798).

Main benefits

• Rated for biological and radiological particulate containment

• Go-to PIU for branches of the U.S. Department of Defense, NATO countries, Federal Emergency Management Agency (FEMA), and their state, regional, and municipal counterparts, as well as domestic and international commercial users such as hospitals, local emergency first response units, and fire departments

• It has been designed to fit on a standard hospital bed or a NATO litter

• The CAPSULS™ is a self-contained device, providing its own battery-powered blower and HEPA filters

• Arm ports on either side of the device allow for attending to the patient during transport

• Completely air and water-tight

• Unrivaled portability

  • Stores down to a size of 24x20x18”

  • Approximately 30 lbs (14 kg)

  • Deployable and operational within 10 minutes